saliva
collect
puuvinfect
patient
hospit
januari
may
depart
infecti
diseas
univers
hospit
sweden
sampl
obtain
patient
typic
clinic
symptom
acut
ne
verifi
detect
puuvspecif
immunoglobulin
ig
serum
puuvspecif
realtim
rtpcr
collect
random
consider
time
day
food
intak
sampl
collect
occas
patient
hospit
ask
patient
spit
singleus
plastic
mug
saliva
remov
syring
ml
becton
dickinson
franklin
lake
nj
usa
put
steril
plastic
test
tube
nunc
roskild
denmark
sampl
immedi
store
analyz
plastic
glove
protect
cloth
use
procedur
total
sampl
store
without
addit
dilut
viru
transport
medium
hepe
bovin
serum
albumin
sucros
fungizon
garamycin
storag
project
approv
research
ethic
committe
univers
patient
gave
written
inform
consent
rna
patient
saliva
plasma
extract
use
qiaamp
viral
rna
kit
qiagen
valencia
ca
usa
accord
manufactur
instruct
realtim
rtpcr
perform
previous
describ
briefli
rna
reversetranscrib
follow
realtim
pcr
taqman
assay
triplet
puuvspecif
primer
probe
segment
realtim
pcr
perform
abi
prism
sequenc
detect
system
appli
biosystem
foster
citi
california
usa
intern
posit
control
use
drosophila
melanogast
fragment
nt
posit
genbank
access
clone
vector
invitrogen
carlsbad
ca
usa
plasmid
linear
restrict
enzym
apai
rna
transcrib
purifi
describ
megascript
high
yield
transcript
kit
ambion
promega
madison
wi
usa
wwwmegasoftwarenet
rna
control
dilut
ad
patient
sampl
use
templat
quantit
realtim
rtpcr
describ
primer
probe
use
amplif
control
rna
melanogast
forward
primer
nm
revers
primer
nm
probe
nm
primer
probe
design
use
primer
express
version
softwar
appli
biosystem
immunofluores
assay
perform
previous
describ
briefli
patient
serum
ad
spot
slide
cover
fix
puuvinfect
vero
cell
igg
level
determin
use
fluoresceinconjug
rabbit
antihuman
igg
dako
glostrup
denmark
dilut
phosphatebuff
salin
pb
evan
blue
igm
analysi
patient
serum
pretreat
rheumatoid
factor
absorb
virionserion
gmbh
germani
elimin
possibl
interfer
rheumatoid
factor
puuvspecif
igg
slide
incub
overnight
antibodi
detect
use
fluoresceinconjug
rabbit
f
antihuman
igm
antibodi
dako
dilut
pb
evan
blue
cdna
patient
saliva
plasma
amplifi
use
pfu
dna
polymeras
fermenta
life
scienc
helsingbord
sweden
sequenc
reaction
perform
use
big
dye
termin
v
cycl
sequenc
kit
appli
biosystem
pcr
sequenc
reaction
perform
primer
ssegment
patient
primer
pcr
follow
sequenc
patient
primer
pcr
follow
sequenc
sequenc
reaction
pcr
fragment
purifi
use
qiaquick
pcr
purif
kit
qiagen
precipit
ethanol
assembl
analysi
align
sequenc
perform
use
geneiou
basic
wwwgeneiouscom
blast
wwwncbinlmnihgovblast
collect
saliva
day
onset
symptom
hospit
ne
patient
determin
whether
hantavirus
present
human
saliva
patient
posit
puuv
rna
plasma
realtim
rtpcr
patient
puuvspecif
igm
antibodi
serum
tabl
analyz
saliva
realtim
rtpcr
presenc
level
viral
rna
saliva
sampl
patient
posit
puuv
rna
rang
puuv
rna
copiesml
demonstr
viral
rna
could
detect
saliva
diseas
tabl
furthermor
detect
inhibit
realtim
rtpcr
saliva
plasma
analyz
patient
sampl
use
intern
posit
control
data
shown
patient
also
igg
posit
serum
vari
titer
studi
detail
whether
rna
detect
saliva
truli
specif
sequenc
region
rtpcr
product
sequenc
amplif
product
saliva
plasma
ne
genbank
access
no
patient
genbank
access
no
patient
genbank
access
no
puuv
ssegment
sequenc
ident
salivaplasma
pair
data
shown
compar
sequenc
patient
found
mismatch
ssegment
sequenc
clearli
demonstr
deriv
differ
strain
figur
observ
nucleotid
mismatch
result
differ
amino
acid
sequenc
sequenc
patient
anoth
ssegment
region
puuv
sequenc
ne
patient
close
relat
puuv
strain
diseaseendem
region
northern
sweden
group
northern
branch
puuv
strain
ne
patient
requir
hospit
care
display
symptom
ne
surviv
none
treat
dialysi
seven
patient
respiratori
symptom
includ
cough
dyspnea
patient
respiratori
symptom
chest
radiograph
reveal
infiltr
data
shown
patient
highest
level
viral
rna
saliva
dyspnea
patient
cough
lung
infiltr
patient
tabl
patient
respiratori
symptom
except
patient
puuv
rna
saliva
investig
show
hantaviru
rna
could
detect
saliva
hfr
patient
found
puuv
rna
vari
puuv
genom
copi
number
saliva
hospit
ne
patient
previous
shown
puuv
rna
plasma
decreas
time
individu
patient
although
studi
find
puuv
saliva
like
would
display
similar
kinet
puuv
viremia
thought
persist
day
studi
patient
puuv
saliva
plasma
day
onset
symptom
furthermor
recent
detect
puuv
rna
plasma
day
first
appear
diseas
would
also
interest
studi
whether
nonhospit
patient
milder
symptom
also
puuv
rna
saliva
know
puuv
rna
saliva
could
origin
puuv
viremia
puuv
rna
detect
saliva
like
produc
salivari
gland
cough
recent
andv
antigen
found
secretori
cell
salivari
gland
human
patient
studi
patient
respiratori
symptom
viru
shed
saliva
known
occur
sever
respiratori
virus
sever
acut
respiratori
coronaviru
respiratori
syncyti
viru
human
metapneumoviru
symptom
upper
respiratori
tract
also
often
present
ne
make
find
puuv
saliva
credibl
one
may
argu
ne
hfr
endem
northern
central
europ
differ
entiti
hcp
caus
sin
nombr
hantaviru
andv
find
viral
rna
saliva
ne
patient
pure
coincid
howev
ne
scandinavia
show
sever
common
characterist
hcp
america
exampl
pulmonari
involv
respiratori
symptom
common
ne
addit
radiolog
infiltr
decreas
pulmonari
function
local
inflammatori
respons
lung
previous
demonstr
could
hantavirus
human
saliva
infecti
initi
infect
today
hantaviru
suggest
transmit
human
andv
use
sophist
epidemiolog
data
ferr
et
al
show
risk
hcp
caus
andv
higher
among
sex
partner
index
case
among
household
contact
investig
suggest
andv
need
close
persontoperson
contact
sexual
relat
deep
kiss
transmit
human
find
hantaviru
saliva
support
conclus
hantaviru
infect
could
transmit
human
saliva
kiss
cough
howev
know
stage
whether
hantaviru
rna
saliva
detect
studi
infecti
tri
infect
bank
vole
human
puuv
saliva
seroconvers
found
day
j
hardestam
et
al
unpub
data
furthermor
success
isol
puuv
saliva
specimen
infect
vero
cell
clinic
isol
hantavirus
grow
readili
cell
line
mutat
noncod
region
shown
need
puuv
strain
kazan
origin
isol
bank
vole
grow
vero
cell
human
puuv
isol
sweden
puuv
strain
adapt
growth
vero
cell
isol
phytohemagglutininstimul
leukocyt
ne
patient
puuv
antigen
detect
month
infect
vero
cell
long
onset
diseas
viral
hantaviru
rna
present
saliva
whether
saliva
contain
neutral
antibodi
need
studi
even
though
andvspecif
iga
antibodi
detect
saliva
patient
acut
hcp
day
onset
symptom
detect
hantavirusspecif
antibodi
human
saliva
may
use
diagnost
detect
viral
rna
saliva
could
use
tool
studi
hantaviru
epidemiolog
andv
rna
shown
present
human
peripher
blood
cell
day
onset
symptom
puuv
rna
detect
plasma
cynomolgu
macaqu
day
symptom
appear
studi
need
determin
whether
true
saliva
anim
model
case
hantaviru
antibodyfre
saliva
could
rather
high
infecti
potenti
hand
saliva
antimicrobi
function
shown
inhibit
certain
virus
influenza
viru
herp
simplex
viru
type
howev
saliva
inhibit
epsteinbarr
viru
adenoviru
far
littl
known
regard
effect
human
saliva
hantaviru
infect
result
experi
perform
indic
human
saliva
could
reduc
least
part
infect
vitro
j
hardestam
et
al
unpub
data
appar
hantavirus
rodent
saliva
infecti
whether
composit
rodent
human
saliva
differ
known
studi
need
elucid
mechan
behind
hantaviru
transmiss
natur
rodent
host
human
find
puuv
rna
saliva
ne
patient
search
evid
possibl
persontoperson
transmiss
puuv
ne
patient
followedup
month
later
discov
sever
cluster
household
member
ne
symptom
howev
none
sever
enough
diseas
requir
physician
care
sampl
collect
laboratori
diagnosi
furthermor
larg
ne
outbreak
earli
high
incid
ne
region
univers
hospit
situat
sinc
patient
live
area
exclud
inhal
rodent
excreta
main
transmiss
rout
although
remain
clearli
shown
result
support
hypothesi
persontoperson
transmiss
may
occur
rout
